Stem cell-based test predicts leukemia patients' response to therapy to tailor treatment
Leukemia researchers at Princess Margaret Cancer Centre have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard ...
Dec 7, 2016
0
137